THERAPEUTIC SOLUTIONS INTERNATIONAL, INC. Financials Therapeutic Solutions International, Inc.
Equities
TSOI
US8833781011
Medical Equipment, Supplies & Distribution
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.0005 USD | -9.09% |
|
-16.67% | -50.00% |
Valuation
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Capitalization 1 | 5.448 | 4.749 | 14.33 | 67.02 | 15.7 | 3.803 |
| Enterprise Value (EV) 1 | 5.93 | 5.704 | 15.12 | 68.03 | 16.76 | 4.663 |
| P/E ratio | -2.64 x | -2.5 x | -5.6 x | -22.2 x | -4.13 x | -1.46 x |
| Yield | - | - | - | - | - | - |
| Capitalization / Revenue | 1,564 x | 173 x | 229 x | 459 x | 76 x | 38.4 x |
| EV / Revenue | 1,702 x | 207 x | 241 x | 466 x | 81.1 x | 47.1 x |
| EV / EBITDA | - | -55,02,772 x | -82,06,903 x | -2,97,54,353 x | -59,12,578 x | -27,84,322 x |
| EV / FCF | 13.6 x | -22.3 x | 240 x | -65.8 x | 27.6 x | -21.4 x |
| FCF Yield | 7.34% | -4.49% | 0.42% | -1.52% | 3.63% | -4.68% |
| Price to Book | -3.07 x | -2.62 x | -8.09 x | -83.3 x | 11.3 x | 3.39 x |
| Nbr of stocks (in thousands) | 9,90,487 | 14,39,038 | 22,25,741 | 23,11,124 | 26,17,391 | 38,02,667 |
| Reference price 2 | 0.005500 | 0.003300 | 0.006440 | 0.0290 | 0.006000 | 0.001000 |
| Announcement Date | 15/04/19 | 21/05/20 | 09/04/21 | 31/03/22 | 29/03/23 | 17/04/24 |
1USD in Million2USD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net sales 1 | 0.003484 | 0.0275 | 0.0627 | 0.146 | 0.2068 | 0.099 |
| EBITDA | - | -1.037 | -1.843 | -2.286 | -2.835 | -1.675 |
| EBIT 1 | -1.2 | -1.043 | -1.85 | -2.304 | -3.08 | -1.986 |
| Operating Margin | -34,437.69% | -3,794.02% | -2,950.78% | -1,578.79% | -1,489.57% | -2,006.67% |
| Earnings before Tax (EBT) 1 | -1.867 | -1.697 | -2.2 | -2.961 | -3.677 | -2.222 |
| Net income 1 | -1.867 | -1.697 | -2.2 | -2.961 | -3.678 | -2.17 |
| Net margin | -53,585.3% | -6,173.2% | -3,509.68% | -2,029% | -1,778.72% | -2,191.86% |
| EPS 2 | -0.002081 | -0.001321 | -0.001150 | -0.001308 | -0.001454 | -0.000684 |
| Free Cash Flow 1 | 0.4352 | -0.2563 | 0.063 | -1.034 | 0.6079 | -0.2182 |
| FCF margin | 12,491.85% | -932.13% | 100.45% | -708.18% | 294.03% | -220.37% |
| FCF Conversion (EBITDA) | - | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - | - |
| Announcement Date | 15/04/19 | 21/05/20 | 09/04/21 | 31/03/22 | 29/03/23 | 17/04/24 |
1USD in Million2USD
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net Debt 1 | 0.48 | 0.96 | 0.79 | 1 | 1.06 | 0.86 |
| Net Cash position 1 | - | - | - | - | - | - |
| Leverage (Debt/EBITDA) | - | -0.9215 x | -0.4278 x | -0.4392 x | -0.3737 x | -0.5137 x |
| Free Cash Flow 1 | 0.44 | -0.26 | 0.06 | -1.03 | 0.61 | -0.22 |
| ROE (net income / shareholders' equity) | 119% | 88.3% | 115% | 229% | -1,269% | -167% |
| ROA (Net income/ Total Assets) | -642% | -252% | -253% | -124% | -72.3% | -36% |
| Assets 1 | 0.2906 | 0.6742 | 0.8701 | 2.384 | 5.083 | 6.028 |
| Book Value Per Share 2 | -0 | -0 | -0 | -0 | 0 | 0 |
| Cash Flow per Share 2 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capex | - | - | 0.01 | 0.26 | - | 0.02 |
| Capex / Sales | - | - | 8.69% | 178.52% | - | 16.32% |
| Announcement Date | 15/04/19 | 21/05/20 | 09/04/21 | 31/03/22 | 29/03/23 | 17/04/24 |
1USD in Million2USD
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
| 1st Jan change | Capi. | |
|---|---|---|
| -50.00% | 2.2M | |
| +10.39% | 126B | |
| -6.86% | 10.96B | |
| +2.52% | 8.97B | |
| +38.96% | 5.56B | |
| -17.50% | 4.99B | |
| +8.36% | 3.44B | |
| -8.84% | 2.8B | |
| -7.52% | 2.18B | |
| -3.00% | 2.16B |
- Stock Market
- Equities
- TSOI Stock
- Financials Therapeutic Solutions International, Inc.